CLINICAL-APPLICATIONS OF CORONARY SINUS RETROPERFUSION DURING HIGH-RISK PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

被引:21
|
作者
INCORVATI, RL
TAUBERG, SG
PECORA, MJ
MACHEREY, RS
KRUCOFF, MW
DIANZUMBA, SB
DONOHUE, BC
机构
[1] MED COLL PENN,ALLEGHENY GEN HOSP,DEPT MED,DIV CARDIOL,CARDIAC CATHETERIZAT LAB,320 E N AVE,PITTSBURGH,PA 15212
[2] DUKE UNIV,MED CTR,DIV CARDIOL,DURHAM,NC 27710
关键词
D O I
10.1016/0735-1097(93)90826-M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study was designed to determine the efficacy of synchronized coronary sinus retroperfusion of arterial blood in reducing myocardial ischemia associated with the performance of high risk coronary angioplasty. Background. Previous animal and clinical work has demonstrated the efficacy of this technique in supporting ischemic myocardium. Methods. Twenty-one patients were randomized to alternately receive coronary sinus retroperfusion support during either the second or the third coronary angioplasty balloon inflation, after an initial unsupported brief control inflation. Myocardial ischemia was assessed by the extent of echocardiographic left ventricular wall motion abnormality, quantified ST segment deviation and hemodynamic and anginal variables during balloon inflations performed with and without coronary sinus retroperfusion support. Regional wall motion score was defined as hyperkinesia (-1), normokinesia (0), hypokinesia (+1), akinesia (+2) and dyskinesia (+3). Results. A reduction in the echocardiographic left anterior descending regional wall motion score in retroperfusion-supported (1.7 +/- 2.1) versus unsupported (2.7 +/- 1.6) inflations (p < 0.05) was noted. Twelve-lead electrocardiographic monitoring revealed no additional ST segment deviation during supported (173 +/- 95 s) compared with unsupported (129 +/- 87 s) angioplasty inflations despite a significantly longer duration of supported inflations (p < 0.004). Mean and peak systolic coronary sinus pressures differed during supported inflations (21 +/- 6 and 44 +/- 13 mm Hg) versus unsupported inflations (10 +/- 4 and 16 +/- 5 mm Hg) (p < 0.001). There was no difference in hemodynamic or anginal variables. Conclusions. A reduction in ischemia as defined by wall motion abnormality during retroperfusion-supported compared with unsupported angioplasty balloon inflations was documented. No additional ST segment deviation occurred during retroperfusion-supported compared with unsupported balloon inflations despite a significantly longer duration of supported inflations. No difference in hemodynamic or anginal variables was noted.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 50 条
  • [21] Prophylactic cardiopulmonary support in high risk percutaneous transluminal coronary angioplasty
    Borges, AC
    Waldenberger, FR
    Wolf, C
    Reindl, I
    Habedank, D
    Haisjackl, M
    Kox, WJ
    Konertz, W
    Baumann, G
    Kleber, FX
    ZEITSCHRIFT FUR KARDIOLOGIE, 1996, 85 : 21 - 28
  • [22] CORONARY RISK FACTOR STATUS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    MCKENNA, KT
    MAAS, F
    MCENIERY, PT
    HEART & LUNG, 1995, 24 (03): : 207 - 212
  • [23] Clinical analysis of coronary artery anomalies and percutaneous transluminal coronary angioplasty
    Li, Shuangbin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C168 - C168
  • [24] RISK STRATIFICATION AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    BURTON, JR
    HARAPHONGSE, M
    HSU, L
    KAPPAGODA, CT
    ROSSALL, RE
    SCHLAUT, B
    SENARATNE, MPJ
    CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 (03) : 687 - 694
  • [25] Troponin T in the coronary sinus and percutaneous transluminal coronary angioplasty related myocardial injury
    Katoh, H
    Shimada, T
    Sano, K
    Inoue, S
    Kitamura, J
    Sakane, T
    Murakami, Y
    Ishibashi, Y
    Karino, K
    Masuda, J
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (1-2) : 14 - 17
  • [26] High-risk percutaneous transluminal coronary angioplasty in hypothermia:: First clinical experience with the new radiant SetPoint system.
    Gerckens, U
    Dae, M
    Müller, R
    Stamm, J
    Grube, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 68G - 68G
  • [27] Coagulation and fibrinolysis during percutaneous transluminal coronary angioplasty
    Varnai, K
    Gurtler, F
    Szatmary, L
    Scholz, ME
    PERFUSION, 1995, 8 (12): : 397 - &
  • [28] INTRACORONARY STENTING DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    ROUBIN, GS
    KING, SB
    DOUGLAS, JS
    LEMBO, NJ
    ROBINSON, KA
    CIRCULATION, 1990, 81 (03) : 92 - 100
  • [29] THROMBOXANE PRODUCTION DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    REBUZZI, AG
    PISANO, E
    MAZZARI, M
    MONGIARDO, R
    BUFFON, A
    TRANI, C
    COPPOLA, E
    CIABATTONI, G
    ARTERIOSCLEROSIS, 1990, 10 (05): : A945 - A945
  • [30] BILATERAL OPHTHALMOPLEGIA DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    DRUMMOND, GT
    WUEBBOLT, G
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1990, 25 (03): : 152 - 155